AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35720170 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) 115 ml daily for 7 days
Number of subjects: 18
Study 35720170 — intervention group
Group type: EXPERIMENTAL
Intervention: Green leafy vegetable juice 250 ml daily for 7 days
Number of subjects: 18
Study 35720170 — intervention group
Group type: COMPARATOR
Intervention: Comparison between BRJ and green leafy vegetable juice
Number of subjects: 18
Study 32950343 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 110
Study 32950343 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone
Number of subjects: 110
Study 32763279 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal BPA exposure
Number of subjects: 96
Study 36427271 — intervention group
Group type: EXPERIMENTAL
Intervention: Immobilization (IM)
Number of subjects: 12
Study 36427271 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal eccentric exercise (MaxEC) after immobilization
Number of subjects: 12
Study 36427271 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study 33419902 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysuria in women aged 15-29
Number of subjects: 1178
Study 33419902 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysuria in women aged 30-44
Number of subjects: 1178
Study 33419902 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms combined for post-test probabilities
Number of subjects: 1178
Study 36309483 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine treatment
Number of subjects: 1362
Study 36309483 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1362
Study 36309483 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported response in vortioxetine-treated patients
Number of subjects: 1362
Study 34136570 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic bag during laparoscopic morcellation
Number of subjects: 48
Study 34136570 — intervention group
Group type: COMPARATOR
Intervention: No bag during laparoscopic morcellation
Number of subjects: 48
Study 35944570 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.25%
Number of subjects: 90
Study 35944570 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.3%
Number of subjects: 90
Study 35944570 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.2%
Number of subjects: 90
Study 34765324 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized lifestyle recommendations
Number of subjects: 25
Study 34765324 — intervention group
Group type: COMPARATOR
Intervention: No recommendations (Control)
Number of subjects: 25
Study 35980237 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofluoric acid + adhesive (HFS-A)
Number of subjects: 96
Study 35980237 — intervention group
Group type: COMPARATOR
Intervention: Hydrofluoric acid (HFS) without adhesive
Number of subjects: 96
Study 35980237 — intervention group
Group type: COMPARATOR
Intervention: Self-etching primer (MEP)
Number of subjects: 96
Study 32044511 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC) using anthracycline-based regimen without taxanes
Number of subjects: 30
Study 32895960 — intervention group
Group type: EXPERIMENTAL
Intervention: Early recurrence (ER) after pulmonary vein isolation (PVI)
Number of subjects: 1285
Study 32895960 — intervention group
Group type: EXPERIMENTAL
Intervention: Reablation subgroup
Number of subjects: 1285
Study 32895960 — intervention group
Group type: EXPERIMENTAL
Intervention: Early recurrence (ER) timing
Number of subjects: 1285
Study 32895960 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC analysis for 14-day blanking period
Number of subjects: 1285
Study 32895960 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC analysis for 30-day blanking period
Number of subjects: 1285
Study 32895960 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 1285
Study 32895960 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with diabetes
Number of subjects: 1285
Study 36958105 — intervention group
Group type: EXPERIMENTAL
Intervention: UVC dwell-time of 8-14 days
Number of subjects: 63
Study 36958105 — intervention group
Group type: COMPARATOR
Intervention: UVC dwell-time of 1-7 days (control group)
Number of subjects: 63
Study 33389369 — intervention group
Group type: EXPERIMENTAL
Intervention: topical timolol 0.5% (n = 16)
Number of subjects: 74
Study 33389369 — intervention group
Group type: EXPERIMENTAL
Intervention: topical brimonidin (n = 15)
Number of subjects: 74
Study 33389369 — intervention group
Group type: EXPERIMENTAL
Intervention: oral acetazolamide 250 mg (n = 14)
Number of subjects: 74
Study 33389369 — intervention group
Group type: EXPERIMENTAL
Intervention: intravenous mannitol (1.5 gr/kg) (n = 16)
Number of subjects: 74
Study 33389369 — intervention group
Group type: COMPARATOR
Intervention: no intraocular pressure-lowering medication (n = 13)
Number of subjects: 74
Study 33174383 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) 3 times weekly for 8 weeks
Number of subjects: 442
Study 33174383 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA) 3 times weekly for 8 weeks
Number of subjects: 442
Study 33174383 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA) 3 times weekly for 8 weeks
Number of subjects: 442
Study 33174383 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA) vs Sham acupuncture (SA)
Number of subjects: 442
Study 33174383 — intervention group
Group type: COMPARATOR
Intervention: Manual acupuncture (MA) vs Sham acupuncture (SA)
Number of subjects: 442
Study 33174383 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) and Manual acupuncture (MA)
Number of subjects: 442
Study 33351101 — intervention group
Group type: EXPERIMENTAL
Intervention: VKA regimen with triple-Antithrombotic therapy
Number of subjects: 0
Study 32706640 — intervention group
Group type: EXPERIMENTAL
Intervention: Postradiation chemotherapy (PCV; procarbazine, lomustine (CCNU), and vincristine)
Number of subjects: 106
Study 32706640 — intervention group
Group type: COMPARATOR
Intervention: Radiation alone (Control)
Number of subjects: 106
Study 35751032 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance 'exercise snacks' performed once daily (n=9)
Number of subjects: 38
Study 35751032 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance 'exercise snacks' performed twice daily (n=10)
Number of subjects: 38
Study 35751032 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance 'exercise snacks' performed thrice daily (n=9)
Number of subjects: 38
Study 35751032 — intervention group
Group type: COMPARATOR
Intervention: Usual-activity control (n=10)
Number of subjects: 38
Study 36364828 — intervention group
Group type: EXPERIMENTAL
Intervention: Food for special medical purposes composed of omega‐3 fatty acids (500 mg), leucine (2.5 g), and probiotic Lactobacillus paracasei PS23
Number of subjects: 60
Study 33332480 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg once daily
Number of subjects: 0
Study 33332480 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 0
Study 34224508 — intervention group
Group type: COMPARATOR
Intervention: Active Stretching (AS)
Number of subjects: 135
Study 34224508 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) + Active Stretching (AS)
Number of subjects: 135
Study 34224508 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) + Active Stretching (AS)
Number of subjects: 135
Study 32769437 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise reduction algorithms and directional microphones activated
Number of subjects: 47
Study 32769437 — intervention group
Group type: COMPARATOR
Intervention: Noise reduction algorithms and directional microphones deactivated
Number of subjects: 47
Study 33064051 — intervention group
Group type: EXPERIMENTAL
Intervention: Cascading classifier approach for TMB topology prediction; two-layers cascading classifier used.
Number of subjects: 0
Study 34587662 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education and exercise (6-month plan created by a physical therapist)
Number of subjects: 104
Study 34587662 — intervention group
Group type: COMPARATOR
Intervention: General feedback after questionnaire (Control)
Number of subjects: 104
Study 35126899 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (supplemented with Western medical treatment)
Number of subjects: 455
Study 35126899 — intervention group
Group type: EXPERIMENTAL
Intervention: Yuebi Jiazhu Tang (subgroup analysis)
Number of subjects: 455
Study 35126899 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganlu Xiaodu Dan (subgroup analysis)
Number of subjects: 455
Study 35126899 — intervention group
Group type: EXPERIMENTAL
Intervention: Yupingfeng granules (subgroup analysis)
Number of subjects: 455
Study 35126899 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medical treatment
Number of subjects: 455
Study 33859084 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal neurotization (CN) - both direct and indirect approaches
Number of subjects: 0
Study 33859084 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal neurotization (CN)
Number of subjects: 0
Study 32678434 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg iron micronutrient powder given in the morning
Number of subjects: 65
Study 32678434 — intervention group
Group type: COMPARATOR
Intervention: 12 mg iron micronutrient powder given in the afternoon
Number of subjects: 65
Study 32678434 — intervention group
Group type: COMPARATOR
Intervention: Consecutive day dosing of 12 mg iron
Number of subjects: 65
Study 32678434 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate day dosing of 12 mg iron
Number of subjects: 65
Study 32678434 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline dose of 12 mg iron
Number of subjects: 65
Study 32678434 — intervention group
Group type: EXPERIMENTAL
Intervention: Every third day dosing of 12 mg iron
Number of subjects: 65
Study 35132421 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral camostat mesylate, 200 mg po four times a day for 7 days
Number of subjects: 70
Study 35132421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 34315440 — intervention group
Group type: EXPERIMENTAL
Intervention: High cognitive leisure activities (CLAs) engagement and high long-chain polyunsaturated fatty acids (LCPUFAs) intake
Number of subjects: 517
Study 34315440 — intervention group
Group type: EXPERIMENTAL
Intervention: Art appreciation as a cognitive leisure activity
Number of subjects: 517
Study 34315440 — intervention group
Group type: EXPERIMENTAL
Intervention: Major LCPUFAs (docosahexaenoic acid and arachidonic acid)
Number of subjects: 517
Study 34174224 — intervention group
Group type: EXPERIMENTAL
Intervention: Group wheelchair maintenance training (two 90-minute classes)
Number of subjects: 147
Study 34174224 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (WLCG)
Number of subjects: 147
Study 32406224 — intervention group
Group type: EXPERIMENTAL
Intervention: Single rehabilitative treatment (ST)
Number of subjects: 63
Study 32406224 — intervention group
Group type: COMPARATOR
Intervention: Group rehabilitative treatment (GT)
Number of subjects: 63
Study 36202162 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure level 30
Number of subjects: 120
Study 36202162 — intervention group
Group type: COMPARATOR
Intervention: Pressure level 20
Number of subjects: 120
Study 33170444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - 10 individual, weekly sessions preoperative
Number of subjects: 0
Study 33170444 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 0
Study 33370549 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Resistance Training (TRT)
Number of subjects: 44
Study 33370549 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit Resistance Training (CRT)
Number of subjects: 44
Study 33370549 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval Resistance Training (IRT)
Number of subjects: 44
Study 33370549 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 44
Study 33556230 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab and bevacizumab combination
Number of subjects: 0
Study 33556230 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 0
Study 32280004 — intervention group
Group type: EXPERIMENTAL
Intervention: Response surface methodology (RSM) optimization for biomass production
Number of subjects: 0
Study 32280004 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimum conditions established by RSM
Number of subjects: 0
Study 32280004 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomass produced
Number of subjects: 0
Study 36380312 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI3902 1500 mg (single intravenous dose)
Number of subjects: 188
Study 36380312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 36380312 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI3902 1500 mg
Number of subjects: 188
Study 33076904 — intervention group
Group type: EXPERIMENTAL
Intervention: Bengali version of the Lequesne Algofunctional index (LAI)
Number of subjects: 130
Study 36273738 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (20 fractions of 20 Gy)
Number of subjects: 133
Study 36273738 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (30 fractions of 60 Gy)
Number of subjects: 133
Study 36273738 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy
Number of subjects: 133
Study 36273738 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 133
Study 36273738 — intervention group
Group type: EXPERIMENTAL
Intervention: RapidPlan left hippocampus sparing model
Number of subjects: 133
Study 33185976 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 78
Study 33185976 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical models
Number of subjects: 78
Study 33185976 — intervention group
Group type: EXPERIMENTAL
Intervention: VR familiarization phase
Number of subjects: 78
Study 33780735 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam (BRV)
Number of subjects: 766
Study 33626005 — intervention group
Group type: EXPERIMENTAL
Intervention: Live Donor Assessment Tool (LDAT)
Number of subjects: 132
Study 33626005 — intervention group
Group type: COMPARATOR
Intervention: Clinical evaluation as usual
Number of subjects: 132
Study 36173726 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally-invasive envelope flap
Number of subjects: 60
Study 36173726 — intervention group
Group type: COMPARATOR
Intervention: Conventional envelope flap
Number of subjects: 60
Study 34220324 — intervention group
Group type: EXPERIMENTAL
Intervention: Low bilirubin group (serum bilirubin≤9.7umol/L, n=753)
Number of subjects: 1492
Study 34220324 — intervention group
Group type: COMPARATOR
Intervention: High bilirubin group (serum bilirubin>9.7umol/L, n=739)
Number of subjects: 1492
Study 34220324 — intervention group
Group type: EXPERIMENTAL
Intervention: Low bilirubin group after PSM (n=566)
Number of subjects: 1492
Study 34220324 — intervention group
Group type: COMPARATOR
Intervention: High bilirubin group after PSM (n=566)
Number of subjects: 1492
Study 32709657 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised, pharmacist led support service focusing on medication adherence and physical comorbidity management.
Number of subjects: 190
Study 32709657 — intervention group
Group type: COMPARATOR
Intervention: Standard care (MedsCheck) provided by pharmacists without additional training.
Number of subjects: 190
Study 32709657 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised, pharmacist led support service.
Number of subjects: 190
Study 33407022 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recess program (EG) - physical exercise at moderate to vigorous intensity with cognitive engagement for 10 weeks, three times a week
Number of subjects: 114
Study 33407022 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 114
Study 35592991 — intervention group
Group type: EXPERIMENTAL
Intervention: Online therapy management system (TMS) with wearable auricular vagus nerve stimulation device
Number of subjects: 0
Study 34708788 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative bevacizumab (BVZ)
Number of subjects: 217
Study 34708788 — intervention group
Group type: COMPARATOR
Intervention: No preoperative bevacizumab (BVZ)
Number of subjects: 217
Study 33040814 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological seawater nasal irrigation combined with oral desloratadine citrate disodium
Number of subjects: 100
Study 33040814 — intervention group
Group type: COMPARATOR
Intervention: Oral desloratadine citrate disodium
Number of subjects: 100
Study 35212308 — intervention group
Group type: EXPERIMENTAL
Intervention: Early complementary acupuncture (once a day for 28 days, starting within 72 hours after injury)
Number of subjects: 0
Study 35212308 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study 33599087 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Dialectical Behaviour Therapy (aDBT-ID)
Number of subjects: 20
Study 33599087 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 20
Study 32899022 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment arm (vitamin K2 isoform 360 mcg 3 times weekly for 18 months)
Number of subjects: 200
Study 32899022 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard care)
Number of subjects: 200
Study 35720174 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised, family-based lifestyle intervention
Number of subjects: 504
Study 35030386 — intervention group
Group type: EXPERIMENTAL
Intervention: Tier 2 interventions in preschool
Number of subjects: 184
Study 35030386 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation (indexed by executive function and teacher‐rated attention)
Number of subjects: 184
Study 33922866 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG‐BF‐guided isometric exercise training with patellar taping
Number of subjects: 60
Study 33922866 — intervention group
Group type: COMPARATOR
Intervention: Sham EMG‐BF training with isometric exercise program
Number of subjects: 60
Study 32985288 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile gel (8.35%)
Number of subjects: 48
Study 32985288 — intervention group
Group type: COMPARATOR
Intervention: Urea cream
Number of subjects: 48
Study 35125276 — intervention group
Group type: EXPERIMENTAL
Intervention: i-PVR group
Number of subjects: 40
Study 35125276 — intervention group
Group type: COMPARATOR
Intervention: ni-PVR group
Number of subjects: 40
Study 36319967 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting hyperkalemia
Number of subjects: 401
Study 33882021 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital behavior change intervention promoting exercise and ocular relaxation with live streaming and peer sharing of activities
Number of subjects: 954
Study 33882021 — intervention group
Group type: COMPARATOR
Intervention: Health education information only (control)
Number of subjects: 954
Study 35583995 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative arts intervention (60 minutes a day, 3 to 4 days a week)
Number of subjects: 20
Study 35583995 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 20
Study 32926847 — intervention group
Group type: EXPERIMENTAL
Intervention: Text parsing tool for identifying poor medication adherence
Number of subjects: 736
Study 32926847 — intervention group
Group type: COMPARATOR
Intervention: Self-reported medication adherence assessment
Number of subjects: 736
Study 32926847 — intervention group
Group type: COMPARATOR
Intervention: EHR documentation of poor adherence
Number of subjects: 736
Study 35192860 — intervention group
Group type: COMPARATOR
Intervention: 75-mg clopidogrel daily (n=80)
Number of subjects: 164
Study 35192860 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75-mg prasugrel daily (n=84)
Number of subjects: 164
Study 33925704 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked ham enriched with antioxidants (100 g/d)
Number of subjects: 65
Study 33925704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 32097140 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-orientated rehabilitation program (ToRP)
Number of subjects: 93
Study 32097140 — intervention group
Group type: COMPARATOR
Intervention: Home-based therapeutic strategies program (Control)
Number of subjects: 93
Study 36240100 — intervention group
Group type: EXPERIMENTAL
Intervention: Telestroke
Number of subjects: 76
Study 36240100 — intervention group
Group type: COMPARATOR
Intervention: PASTA
Number of subjects: 76
Study 33691439 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 150
Study 33691439 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyclonine hydrochloride mucilage
Number of subjects: 150
Study 33691439 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (EA + dyclonine hydrochloride)
Number of subjects: 150
Study 35549750 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dressings with Mastisol liquid adhesive (MLA)
Number of subjects: 160
Study 35549750 — intervention group
Group type: COMPARATOR
Intervention: Standard dressings (control)
Number of subjects: 160
Study 33798487 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of moxidectin
Number of subjects: 223
Study 33798487 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of moxidectin
Number of subjects: 223
Study 33798487 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg of moxidectin
Number of subjects: 223
Study 33798487 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg of moxidectin
Number of subjects: 223
Study 33798487 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of moxidectin
Number of subjects: 223
Study 33798487 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg of moxidectin
Number of subjects: 223
Study 33798487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study 35956073 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% hyaluronic acid and 0.2% galacto‐xyloglucan (HA-GX)
Number of subjects: 34
Study 35956073 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid alone (HA)
Number of subjects: 34